Process Capability
A statistical measure of how consistently a process produces output within specified acceptable limits, assessing whether it reliably meets targets.
Explore comprehensive, evidence-informed explanations of key health economics concepts, including their development, application and relationships to other concepts. Published entries are validated through human expert review.
A statistical measure of how consistently a process produces output within specified acceptable limits, assessing whether it reliably meets targets.
The difference between the price a producer receives and the minimum they would have accepted, the net benefit they gain from a transaction.
The branch of microeconomic theory analysing how firms choose inputs and output levels to maximise profit given their costs and market conditions.
The formal statistical name for the Kaplan-Meier estimator, reflecting its calculation as a running product of conditional survival probabilities.
A graph showing the maximum combinations of two goods or outcomes producible given a fixed set of resources and existing technology.
A condition in which a given output level is produced using the minimum possible inputs, synonymous with technical efficiency.
A budgeting approach that organises spending around specific programmes or services rather than departmental line items.
A budgeting approach organising health spending around specific programmes or disease areas rather than input categories, allowing cross-programme comparison.
A time-to-event measure defined as the time from treatment start until either disease progression or death from any cause, whichever occurs first.
The estimated probability that an individual would receive a particular treatment given their observed characteristics, used to balance confounders in observational studies.
A statistical technique pairing treated individuals with similar untreated individuals based on an estimated propensity score, balancing measured confounding variables.
A quantitative adherence measure calculated as the proportion of days a patient had access to medication, accounting for overlapping supply more precisely than MPR.
The Cox model assumption that the hazard ratio between two groups stays constant over follow-up, even as the absolute hazard rate changes.
A measure of disease severity calculated as the proportion, rather than absolute number, of expected quality-adjusted life years lost to a condition.
A risk adjustment method using prior period diagnoses to predict a subsequent period's costs, unlike concurrent adjustment using same-period data.
Provider payment refers to the methods and arrangements through which healthcare providers are paid for delivering services, including fee-for-service, capitation, bundled payments, salaries, global budgets and value-based payment.
A number generated by a deterministic algorithm that approximates the statistical properties of true randomness, used because genuine randomness is hard to compute.
The process of computing quality-adjusted life years by multiplying time spent in a health state by its utility value, then summing across states.
The increase in quality-adjusted life years attributable to an intervention, the difference between the QALYs expected under it and its comparator.
A matrix factorisation method that expresses a matrix as the product of an orthogonal matrix and an upper triangular matrix.